Iovance Biotherapeutics Inc [NASDAQ: IOVA] price plunged by -2.08 percent to reach at -$0.25. The one-year IOVA stock forecast points to a potential upside of 54.69. The average equity rating for IOVA stock is currently 1.29, trading closer to a bullish pattern in the stock
Iovance Biotherapeutics Inc [NASDAQ: IOVA] jumped around 0.54 points on Tuesday, while shares priced at $11.86 at the close of the session, up 4.77%. Compared to the average trading volume of 9.05M shares, IOVA reached a trading volume of 3876426 in the most recent trading
Iovance Biotherapeutics Inc [NASDAQ: IOVA] closed the trading session at $11.89. The stocks have a year to date performance of 46.25 percent and weekly performance of -9.03 percent. The stock has been moved at 227.55 percent over the last six months. The stock has performed
Iovance Biotherapeutics Inc [NASDAQ: IOVA] price surged by 1.15 percent to reach at $0.15. The company report on March 22, 2024 at 5:30 PM that Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4). The awards were granted under Iovance’s 2021 Inducement Plan, which
Iovance Biotherapeutics Inc [NASDAQ: IOVA] loss -2.96% or -0.42 points to close at $13.77 with a heavy trading volume of 5512913 shares. The company report on March 22, 2024 at 5:30 PM that Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4). The awards
Iovance Biotherapeutics Inc [NASDAQ: IOVA] closed the trading session at $14.10. The company report on March 22, 2024 at 5:30 PM that Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4). The awards were granted under Iovance’s 2021 Inducement Plan, which was adopted on
Iovance Biotherapeutics Inc [NASDAQ: IOVA] stock went on a downward path that fall over -2.11% on Friday, amounting to a one-week price decrease of less than -11.40%. The company report on March 4, 2024 at 6:30 AM that Iovance Biotherapeutics Announces FDA has Lifted Clinical
Iovance Biotherapeutics Inc [NASDAQ: IOVA] stock went on a downward path that fall over -5.54% on Firday, amounting to a one-week price decrease of less than -6.49%. The company report on March 4, 2024 at 6:30 AM that Iovance Biotherapeutics Announces FDA has Lifted Clinical
Iovance Biotherapeutics Inc [NASDAQ: IOVA] gained 5.53% or 0.88 points to close at $16.79 with a heavy trading volume of 10992444 shares. The company report on March 1, 2024 at 5:00 PM that Iovance Biotherapeutics to Present at Upcoming Conferences. Iovance Biotherapeutics, Inc. (NASDAQ: IOVA),
Iovance Biotherapeutics Inc [NASDAQ: IOVA] loss -1.07% on the last trading session, reaching $15.77 price per share at the time. The company report on February 22, 2024 at 8:45 AM that Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and
© 2024, Powered by Smart TechOne
